Back to NBIX
TRUIST FINANCIAL CORP NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
15
Latest value
$3K
Q3 2026
Peak value
$4.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3K |
| Q3 2025 | $4.2M |
| Q3 2025 | $761K |
| Q4 2025 | $3K |
| Q4 2025 | $763K |
| Q4 2025 | $793K |
| Q1 2026 | $3K |
| Q1 2026 | $708K |
| Q1 2026 | $760K |
| Q2 2026 | $1.3M |
| Q2 2026 | $1.7M |
| Q2 2026 | $4K |
| Q3 2026 | $1.1M |
| Q3 2026 | $1.4M |
| Q3 2026 | $3K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3K | 23 | — | — |
| Q3 2026 | $1.4M | 10.0K | — | — |
| Q3 2026 | $1.1M | 8.0K | — | — |
| Q2 2026 | $4K | 23 | — | — |
| Q2 2026 | $1.7M | 10.3K | — | — |
| Q2 2026 | $1.3M | 7.6K | — | — |
| Q1 2026 | $760K | 5.8K | — | — |
| Q1 2026 | $708K | 5.4K | — | — |
| Q1 2026 | $3K | 23 | — | — |
| Q4 2025 | $793K | 5.6K | — | — |
| Q4 2025 | $763K | 5.4K | — | — |
| Q4 2025 | $3K | 23 | — | — |
| Q3 2025 | $761K | 5.4K | — | — |
| Q3 2025 | $4.2M | 29.9K | — | — |
| Q3 2025 | $3K | 23 | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M